Li Yan Chun
Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. cyan @ medicine.bsd.uchicago.edu
Contrib Nephrol. 2013;180:98-109. doi: 10.1159/000346789. Epub 2013 May 3.
Vitamin D deficiency is highly prevalent in patients with chronic kidney disease (CKD). The low vitamin D status is, to a large extent, caused by dysregulation of vitamin D metabolism as a result of renal insufficiency. Recent studies indicate that vitamin D-deficiency may promote or accelerate the progression of CKD, whereas treatment with low calcemic vitamin D analogs can reduce proteinuria and ameliorate renal damage in animal models of kidney disease and in patients with CKD. The renoprotective activity of vitamin D regulates multiple signaling pathways known to play important roles in renal injury. These findings underscore the importance of correcting vitamin D deficiency with vitamin D supplementation or with activated vitamin D analogs in the management of CKD.
维生素D缺乏在慢性肾脏病(CKD)患者中极为普遍。维生素D水平低下在很大程度上是由于肾功能不全导致维生素D代谢失调所致。最近的研究表明,维生素D缺乏可能促进或加速CKD的进展,而使用低钙血症维生素D类似物进行治疗可减少蛋白尿,并改善肾病动物模型和CKD患者的肾损伤。维生素D的肾脏保护活性调节多种已知在肾损伤中起重要作用的信号通路。这些发现强调了在CKD管理中通过补充维生素D或使用活性维生素D类似物纠正维生素D缺乏的重要性。